Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GLOBUS MEDICAL INC | Director | Class A Common Stock | 25.4K | $1.48M | $58.46 | Sep 15, 2025 | Direct |
QuidelOrtho Corp | Director | Common Stock | 14.3K | $396K | $27.78 | May 24, 2025 | Direct |
QuidelOrtho Corp | Director | Restricted Stock Units (Premium) | 325 | $9.28K | $39.64 | May 29, 2025 | Direct |
QuidelOrtho Corp | Director | Restricted Stock Units (Equity Grant) | 6.83K | $0 | $39.64 | May 29, 2025 | Direct |
QuidelOrtho Corp | Director | Restricted Stock Units (Converted) | 1.63K | $0 | $44.19 | May 29, 2025 | Direct |
Evoke Pharma Inc | Director | Stock Option (Right to Buy) | 61.8K | May 5, 2021 | Direct | ||
Repare Therapeutics Inc. | Director | Stock Option (right to buy) | 27.2K | Jun 17, 2024 | Direct | ||
GLOBUS MEDICAL INC | Director | Stock Option (Right to Buy Class A Common Stock) | 15K | Jan 23, 2025 | Direct | ||
iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Aug 29, 2025 | Direct | ||
QUIDEL CORP /DE/ | Director | Common Stock | 0 | May 27, 2022 | Direct | ||
QUIDEL CORP /DE/ | Director | Restricted Stock Units | 0 | May 27, 2022 | Direct | ||
QUIDEL CORP /DE/ | Director | Restricted Stock Units (Equity Grant) | 0 | May 18, 2022 | Direct | ||
QuidelOrtho Corp | Director | Restricted Stock (Premium) | 0 | Jun 6, 2024 | Direct |